Mutuelles Impact
VC Fund
Mutuelles Impact is a VC fund focused on Health Care and Medical Device. Mutuelles Impact Initiated by the Mutualité Française and financed by 45 mutuals and the Mutualité Française, the Mutuelles Impact fund aims to invest and develop companies with a high social impact in the sectors of prevention, care pathways, and medico-social.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 42%
Last updated:
For AI agents: llms.txt
Industries Mutuelles Impact invests in
Stages Mutuelles Impact invests in
Countries Mutuelles Impact invests in
Round sizes
Round size
- Seed
- $2.3M–$15M
- Series B
- $14M–$28M
- Venture - Series Unknown
- $3.6M–$25M
Investment Focus
Industry
- Health Care 12 (63%)
- Medical Device 6 (32%)
- Software 4 (21%)
- Wellness 4 (21%)
- Medical 3 (16%)
Stage
- Seed 7 (37%)
- Venture - Series Unknown 4 (21%)
- Series B 2 (11%)
- Funding Round 2 (11%)
- Series A 1 (5%)
Country
- France 14 (74%)
- Germany 1 (5%)
- Switzerland 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Semeia
|
Semeia provides software that helps in medical follow-up and consultation. | $24.7M / Venture - Series Unknown / May 11, 2026 | |
Mindday
|
Mindday is reinventing mental well-being by combining human support, digital programs and science to provide immediate and personalized support to anyone. | $2.3M / Seed / Mar 24, 2026 | |
Lifeaz
|
Lifeaz saves lives by developing a new generation of connected, simpler, more reliable and smarter defibrillators. | $15.4M / Seed / Feb 12, 2026 | |
Wandercraft
|
Wandercraft develops autonomous walking exoskeletons and robotic systems designed to restore upright mobility to individuals with walking impairments. The company offers devices such as Atalante X, a hands‑free, self‑balancing exoskeleton used in rehabilitation centers, and a Personal Exoskeleton prototype that leverages AI‑driven balance tosupport walking in daily life. Their systems incorporate real‑time adaptive gait algorithms and powered joints to facilitate multidirectional movement and support early intensive rehabilitation. Wandercraft collaborates with healthcare institutions and has initiated clinical trials to evaluate safety and effectiveness in managing spinal cord injuries and stroke rehabilitation. | $75M / Series D / Jun 06, 2025 | |
Ensweet
|
Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation. | $3.4M / Seed / May 20, 2025 | |
Diagnoly
|
Diagnoly develops an AI-powered medical plug-in device that analyzes fetal examination in real-time and helps doctors to detect the most complex fetal pathologies. | $6M / Seed / Apr 08, 2025 | |
HelloBetter
|
HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services. | $6.5M / Venture - Series Unknown / Mar 05, 2025 | |
Lyv
|
Lyv helps people sufferin | $2.7M / Seed / Feb 04, 2025 | |
SURGAR
|
SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery. | $12.3M / Venture - Series Unknown / Sep 26, 2024 | |
SamanTree Medical
|
SamanTree Medical is a swiss innovative medical device company providing a breakthrough imaging solution with the potential to improve patient care and cancer surgery outcome. Based on confocal microscopy, SamanTree Medical’s solution brings accurate and full margin control by the surgeon, in the operating room. | $14M / Series B / Jul 16, 2024 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mutuelles Impact invest in?
Mutuelles Impact invests primarily in Health Care, Medical Device and Software startups, most often at Seed and Venture - Series Unknown stage. Most of the 19 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mutuelles Impact's check size?
Mutuelles Impact typically joins rounds of $2.3M–$15M at Seed, $14M–$28M at Series B and $3.6M–$25M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mutuelles Impact participates in.
When did Mutuelles Impact last invest?
The most recent investment recorded for Mutuelles Impact closed in May 2026. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
